In its latest report on Transplant Diagnostic Market provides a concise analysis of the recent market trends. The report further includes statistics, market forecasts and revenue estimations, which in addition highlights its status in the competitive domain as well as expansion trends adopted by major industry players.
Transplant Diagnostic Market Size
Global Transplant Diagnostic Market is valued at USD 3.54 Billion in 2020 and expected to reach USD 5.80 Billion by 2027 with a CAGR of 7.3% over the forecast period.
Get Sample Copy of This Premium Report @ https://brandessenceresearch.com/requestSample/PostId/921
Scope of Global Transplant Diagnostic Market Report
Transplant diagnostics are the tests led before movement/transplantation of the giver organ to recipient patient. HLA typing is one of most extreme significant applications, for example, organ and blood stem cell transplantation. Transplant diagnostics tests incorporate Human leukocyte antigen (HLA) diagnostic testing, PCR-based assay, serological test and blended lymphocyte culture (MLC) measure among others.
Organ transplantation is a process where healthy organ from one person (alive/dead) is removed out and placed into recipient’s body (alive) that needs it for effective functioning of life. Organs that can be medically transplanted are kidneys, heart, lungs, intestine, liver, thymus and pancreas. Tissues that can be medically transplanted are bones, cornea, heart valves, veins, nerves, skin and tendons. Out of the entire most commonly transplanted organ is Kidney which is preceded by liver and then heart. Sir Peter Medawar is known as father of transplantation who worked on graft rejection and acquired immune tolerance in 1944 showed that skin allograft between two mice are rejected. On march 9th 1981 the first successful heart lung transplant took place at Stanford university hospital. The surgeon, Bruce Reitz, credited the patients recovery to cyclosporine-A.
The COVID-19 pandemic has shown a decline impact on the organ donation and transplantation in countries that have experienced high rates of infection. During COVID-19 pandemic, government imposed a restriction on transportation to reduce the risk of infection which pauses of elective surgeries in all specialties of medicine including the transplant diagnosis. Due to lockdown conditions and social distancing the transplant diagnostic were delayed or postponed. The imposition of lockdown measures urged the R&D personnel as well as clinical trials of the organizations various ways.
Global Transplant Diagnostic Market Segmentation:
Global transplant diagnostic market is segmented on the basis of technology, product & service, organ type, application, end-user and region & country level. Based upon technology, transplant diagnostic market is classified into molecular assay and non-molecular assay. Based upon product & service, the market is divided into reagents, instruments and software’s. Based on organ type, the transplant diagnostic market is classified into kidney, lungs, pancreas and heart. Based upon application, the market is divided into research and diagnostic. Based on organ end-user, the transplant diagnostic market is classified into hospital, research center, transplant center and commercial provider.
By Technology:
- Molecular Assay
- Non-molecular assay
By Product & Service:
- Reagents
- Instruments
- Software’s
By Organ Type:
- Kidney
- Lungs
- Pancreas
- Heart
By Applications:
- Research
- Diagnostic
By End-User:
- Hospital
- Research center
- Transplant center
- Commercial provider
The regions covered in this global transplant diagnostic market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, the market of transplant diagnostic is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, Middle East Asia (UAE, Saudi Arabia, Egypt) GCC, Africa, etc.
Transplant Diagnostic Companies
Some major key players for global transplant diagnostic market report cover prominent players like
- Cylex Inc.
- Transonic
- Stryker
- LXN Corporation
- Alpha Laboratories
- Horiba Medical
- Randox Laboratories Ltd
- Thermo Fisher Scientific Inc.
- Otsuka Holdings Co Ltd.
- Medtronic
- Hoffmann-La Roche Ltd.
- Novartis AG
- Pfizer Inc.
- Sanofi
- Terumo Corporation
- Preservation Solutions Inc.
- Laboratory Corporation of America Holdings
- TransMedics Inc.
- AbbVie Inc.
- Zimmer Biomet
- NHS Blood and Transplant and others.
Request for Methodology @ https://brandessenceresearch.com/requestMethodology/PostId/921
Transplant Diagnostic News
Thermo Fisher Scientific Signed Partnership Agreement with the New Terasaki Innovation Center for Transplant Diagnostic Research
On October 29th, 2020; Thermo Fisher Scientific signed a partnership agreement with the recently formed Terasaki Innovation Center (TIC) to work with discovery and improvement of new pathways and devices to analyze and improved manage transplant patients. Thermo Fisher will have the principal choice to produce new advancements created by the TIC for use by clinicians, labs, and transplant centers all throughout the globe. Thermo Fisher’s transplant diagnostics business is focused on improving the existences of patients worldwide by driving development and conveying quality products. The organization’s inclusive item portfolio incorporates an expansive scope of antibody detection assays, post-transplant monitoring solutions including the novel Molecular Microscope Diagnostic System, HLA composing items, lab instrumentation and software, and industry-leading client support.
Rising Prevalence of Chronic and Infectious Diseases, Increasing Awareness Related to the Transplant Diagnostic Procedures and Growing R&D Activities are Some Major Factors Driving the Market Growth
Rising occurrence of chronic and infectious diseases is one of the major factors for driving the growth of global transplant diagnostic market. For instance; as indicated by WHO, in 2020, chronic diseases will represent right around three-quarters of all deaths around the world, and that 71% of deaths because of ischemic heart diseases (IHD), 75% of deaths because of stroke, and 70% of deaths because of diabetes will happen in developing nations. In addition, increasing awareness related to the transplant diagnostic procedures is another major factor supplementing the market growth. For example; according to US department of health and human services, 39,718 transfers were performed in 2019. Also, as indicated by HRSA, in excess of 113,000 individuals are in the waiting list for organ relocate in 2019. As per Health Resources and Services Administration, starting at 2019, each 10 minute an individual is being added to this waiting list for organ transfers.
Furthermore, growing R&D activities in this field are also fostering the growth of global transplant diagnostic market. For instance; in January 2020; the main American transplant diagnostics organization Eurofins Viracor presented its exclusive dd-cfDNA (contributor determined sans cell DNA) test, named Viracor TRAC. The new advancement is an expansion to the company’s wide-ranging collection of kidney transplant diagnostics.
However, high development cost of organ transplant and inappropriate values of the organ and surgery which may hamper the global transplant diagnostic market growth. In spite of that, development of advance technologies for successful organ transplant can offer more opportunities for the further growth of the global transplant diagnostic market over the forecast period.
Complete Report Details @ https://brandessenceresearch.com/healthcare/transplant-diagnostics-market-size
North America Expected to Dominate the Global Transplant diagnostics Market
North America is expected to dominate the global transplant diagnostic market over the forecast period due to technological advancements, rising volume of organ transplantation procedures performed and presence of key players in this region. For instance; in February 2019, Care Dx dispatched the Allosure for lung transfers. According to Health Resources and Services Administration in 2019, the quantity of individuals requiring organ transplantation in the U.S. was 112,568, while the number of organ donor was pretty much as low as 19,267. Asia Pacific is expected to witness a fastest growth rate in the transplant diagnostic market over the forecast period due to the increasing chronic diseases, large patient population and improving healthcare infrastructure in this region.
By Regional & Country Analysis: (North America, U.S., Canada, Europe, U.K., France, Germany, Italy,Asia Pacific, China, Japan, India, Southeast Asia, Latin America, Brazil, Mexico, Middle East and Africa, GCC, Africa, Rest of Middle East and Africa)
Key Benefits of Global Transplant Diagnostic Market Report–
- Global Transplant Diagnostic Market report covers in-depth historical and forecast analysis.
- Global Transplant Diagnostic Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level.
- Global Transplant Diagnostic Market report helps to identify opportunities in marketplace.
- Global Transplant Diagnostic Market report covers extensive analysis of emerging trends and competitive landscape.
Table of Content
1. Chapter – Report Methodology
1.1. Research Process
1.2. Primary Research
1.3. Secondary Research
1.4. Market Size Estimates
1.5. Data Triangulation
1.6. Forecast Model
1.7. USP’s of Report
1.8. Report Description
2. Chapter – Global Transplant Diagnostic Market Overview: Qualitative Analysis
2.1. Market Introduction
2.2. Executive Summary
2.3. Global Transplant Diagnostic Market Classification
2.4. Market Drivers
2.5. Market Restraints
2.6. Market Opportunity
2.7. Transplant Diagnostic Market: Trends
2.8. Porter’s Five Forces Analysis
2.9. Market Attractiveness Analysis
3. Chapter – Global Transplant Diagnostic Market Overview: Quantitative Analysis
4. Chapter – Global Transplant Diagnostic Market Analysis: Segmentation By Type
5. Chapter – Global Transplant Diagnostic Market Analysis: Segmentation By Application
Continued…..
About Us: Brandessence Market Research and Consulting Pvt. ltd.
Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.
Contact us at: +44-2038074155 or mail us at sales@brandessenceresearch.com
Website: https://brandessenceresearch.com/
Article: https://businessstatsnews.com
